🧵3/3
LA-GLOBAL sits in our Partnership Coordination project, funded by @unitaid.bsky.social.
We're aiming for accessible attendance for delegates from LMICs to align with the mission to accelerate equitable health outcomes of long-acting science, particularly for communities in LMICs.
🧵2/3
LA-GLOBAL spotlights progress and innovation while fostering partner commitments with enlightening presentations, keynote speakers, panels and networking.
The programme combines plenary discussions, technical tracks, implementation showcases and policy dialogues.
@livuniresearch.bsky.social
The LA-GLOBAL logo is above the text "A brand new conference to accelerate the translation of long-acting science into equitable health outcomes. 29-30 November, Liverpool UK" above a picture of Liverpool with the Spine building at the forefront and the CELT Global Health and Unitaid logos.
📣 NEW CONFERENCE!
We're extremely pleased to announce we're hosting a new conference this year!
🌟 LA-GLOBAL
📆 29-30 November 2026
📍 Liverpool, UK
www.liverpool.ac.uk/celt-global-...
Registration, abstracts and sponsorship details will be released over the coming weeks.
🧵1/3
@livunihls.bsky.social
The World Hepatitis Summit logo with 2026 next to it
Just after #WorldLiverDay, we're excited a #LONGEVITYproject Community Advisory Board member is presenting ‘Surveys on preferences and feasibility of long-acting technologies for the treatment of Hepatitis C Virus’ at the World Hepatitis Summit next week.
www.liverpool.ac.uk/celt-global-...
An image of people networking at last year's LAAI, the LAAI logo and the text "register today, be part of the global conversation on long-acting solutions"
The 2nd International Workshop on Long-acting anti-infectives (LAAI 2026) is next month 21-22 April. We're pleased to endorse this event and hope to see some of you there.
Find out more about events we're presenting at or endorsing on our events page: www.liverpool.ac.uk/celt-global-...
The poster has the HALo logo and Making Pharmaceuticals logo, then the event information listed in our post.
Our Co-Director and HALo Director, Prof. Steve Rannard and Co-Investigator Dr Tom McDonald are presenting 'Opportunities for Long-acting Therapeutics in the UK' at Making Pharmaceuticals next week.
We also have several poster presentations.
Find out more:
www.liverpool.ac.uk/celt-global-...
While there have been various webinars, bringing as many of the group into one room as we could was such a powerful experience.
The breakout groups discussing and dissecting our various themes has led to this energising piece of work.
Funded by @unitaid.bsky.social
@livuniresearch.bsky.social
We're proud the first white paper from our Community of Practice for long-acting therapeutics for maternal and paediatric health has been published in @ascptclinpharm.bsky.social.
The impact of genuine international collaboration is evident throughout:
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
LA-LINK workshops are part of our Partnership Coordination project, funded by @unitaid.bsky.social.
The project incorporates knowledge sharing activities to accelerate equitable access to long-acting products in LMICs.
Find out more about the project: www.liverpool.ac.uk/celt-global-...
a chain hangs down with an image of a glowing lightbulb over a global heat map. Text reads "LA-LINK. Putting community voices at the centre of access to long-acting medicines. 6 May 2026, online, the second LA-LINK workshop"
📣 New LA-LINK Workshop!
Our quarterly online workshop series from researchers, regulators, manufacturers and patient advocates and more.
⭐Putting community voices at the centre of access to long-acting medicines
📆29 January
✅Registration open soon
www.liverpool.ac.uk/celt-global-...
a global heat map with pins has the blog title written over the top: We're a preclinical team with a focus on manufacturing capability - Here's why.
A large step towards addressing global inequality of access to long-acting therapeutics will be utilising local manufacturing.
We're working to create a free resource highlighting what manufacturing capabilities are available in which regions.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Our Community of Practice for long-acting therapeutics for maternal and paediatric health is funded by global health agency @unitaid.bsky.social.
We're working hard to create stronger pathways for maternal patient inclusion in clinical trials.
Find out more: www.liverpool.ac.uk/celt-global-...
11 April was #InternationalDayforMaternalHealthRights
We recorded 'Clinical and pharmacogenomics considerations for the use of long-acting antipsychotics in pregnancy'
The workshop was led by James Lee from @dptnhs.bsky.social and Prof. Jeff Bishop from @umnpharmacy.bsky.social
youtu.be/3CpCJS1QjFg
An illustration of a hepatitis C virus
We have a page for each of the #LONGEVITYproject diseases that explains:
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The LAPaL logo is the word LAPaL with 'the long-acting therapeutics patents and licences database' underneath.
Recently LAPaL updates
New drug delivery technologies:
Multi-Arm Polymer Conjugated Immunotherapies
Plexis Long-acting Injectable Technology
New drugs:
GS-3242
Acoziborole
And we've updated:
Ulonivirine
VH-499
VH-148
Alimatravir
GS-3107
www.liverpool.ac.uk/celt-global-...
@medicinespatentpool.org
A patient's arm is being prepped for an injection
This week's news from other long-acting therapeutics research includes:
💉Apogee Therapeutics announces positive Phase 2 of Zumilokibart, with every 3- and 6-month dosing in moderate-to-severe atopic dermatitis.
Read the full story and others on our Global News: www.liverpool.ac.uk/celt-global-...
A person is reading the news on their tablet.
This week's global news from other long-acting research teams includes:
@cuanschutz.bsky.social find that monthly HIV injections are more effective for people struggling with treatment adherence than daily pills
Read this story and more on our Global News page: www.liverpool.ac.uk/celt-global-...
🧵2/2
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
A woman looks over the land at the sunrise. Text reads "Subscribe to our mailing list"
🧵1/2
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
A picture of James Lee from Devon Partnership NHS Trust and Prof. Jeff Bishop from University of Minnesota next to the text "27.03.26 4-5.30pm (GMT), Community of Practice for long-acting therapeutics for maternal and paediatric health webinar: Clinical and Pharmacogenomics considerations for the use of long-acting antipsychotics in pregnancy"
Our next Community of Practice webinar:
🌟Clinical and pharmacogenomic considerations for the use of long-acting antipsychotics in pregnancy
📆Fri 27 March, 4-5.30pm (GMT)
📍Online
🗣️James Lee - Devon Partnership NHS
Professor Jeff Bishop - @umnpharmacy.bsky.social
www.liverpool.ac.uk/celt-global-...
Did you see our demonstration of Teoreler 2.0?
If not, we have a recording from the pharmacometric LA-LINK workshop where it was demonstrated.
Teoreler 2.0 is free simulation software, that it is browser based with no downloads necessary.
www.youtube.com/watch?v=_pF4...
@unitaid.bsky.social
We want to share this snippet video from @seftoncu.bsky.social.
HALo's Director and PPIE coordinator, delivered 'Marvelous Medicine'. Over 1200 year 6s from 40 classrooms learnt all about the importance and history of medicine for #BritishScienceWeek!
www.instagram.com/reel/DVvrFK1...
@EPSRC
Professor Steve Rannard receiving the Runner Up SCI Forum Award
📣We received the @sciupdate.bsky.social Formulation Forum Innovation Runner Up Award!
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
The Manufacturing Capability logo is the project title to the right of a celtic knot and "CELT Global Health" underneath.
Our Manufacturing Capability project facilitates development and manufacture of LATs globally with a LMIC focus
We will:
🏭Assess current CMO capability
🤝Engage with stakeholders with LAT manufacturing capabilities
🌍Create an open access LAT developer resource
www.liverpool.ac.uk/celt-global-...
📣FULLY FUNDED PhD STUDENTSHIP
The Perinatal Pharmacology Group are recruiting a fully funded PhD student that will involve working with us (Centre of Excellence for Long-acting Therapeutics - Global Health).
Deadline: 20 March 2026
Find out more: www.liverpool.ac.uk/celt-global-...
Dr Marcia Vermeulen is behind a lectern presenting a talk at the University of Cape Town. The blog title is written over the top "From vision to impact: Redefining STEM by closing the gender gap with Dr Marcia Vermeulen".
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The skyline of Nairobi city in Kenya as the sun rises.
This week's news from other long-acting therapeutics teams:
💉Kenya launches long-acting HIV prevention injection
🏭South Africa launch bid to enable local production of lenacapavir
🧪ViiV Healthcare report two long-acting HIV treatment findings
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
🧵2/2
🌍Lead stakeholder engagement across global networks and strengthen partnerships across the @unitaid.bsky.social funded Community of Practice
🗣️Run surveys, workshops and evidence‑gathering activities
📑Support production of quality evidence syntheses, best‑practice resources and policy outputs.
An colourful image of the University of Liverpool. The text reads "Stakeholder Engagement Officer, Grade 7 (£39,906 - £46,049pa), full time working hours, fixed term until 31 December 2027, on the Liverpool campus".
🧵1/2
📣JOB ADVERT!
🌟Stakeholder Engagement Officer
Join a team accelerating long‑acting medicines for maternal and children's health priorities worldwide, within the Perinatal Pharmacology group with Dr @aeolagunju, Prof Andrew Owen and Prof Steve Rannard
www.liverpool.ac.uk/celt-global-...
A solar system made up of "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
#LONGEVITYproject is a consortium researching long-acting malaria and TB preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social